Interfering substances. Interference in the Fungitell assay due to hemolysis,
bilirubin, and lipemia was assessed by supplementation of a BG-positive serum
sample with each of the individual interferents (25). To prepare sufficient quantities
of BG-positive serum samples for this study, a unit of expired fresh frozen
plasma that tested negative for BG was clotted with CaCl2. Serum was collected
by centrifugation and sterilely filtered. A BG-positive serum sample control was
produced by reconstituting lyophilized BG from Associates of Cape Cod, Inc.,
with the above-processed serum to a concentration of 161 pg/ml. The BG standard
(pachyman) used in this study was the same as that supplied with the
Fungitell kit. Bilirubin and triglycerides (Intralipid) were purchased from Sigma,
St. Louis, Mo. A solution of hemoglobulin was prepared by lysis of washed red
blood cells with pyrogen-free water (Associates of Cape Cod, Inc.). Stock solutions
of bilirubin, triglycerides, and hemoglobulin, prepared in pyrogen-free
water, were added individually to aliquots of the BG-positive serum prepared
above to simulate a range of bilirubin, triglyceride, and hemoglobin concentrations
of approximately 0 to 200 mg/dl, 0 to 1,000 mg/dl, and 0 to 2,500 mg/dl,
respectively. Final concentrations of hemoglobin, bilirubin, and triglycerides
were determined for each aliquot. Bilirubin and triglycerides were determined
with a Modular Analytics P instrument (Roche Diagnostics Corporation, Indianapolis,
Ind.) using reagents supplied by the manufacturer. Hemoglobin concentration
was determined with a Beckman Coulter DU 800 spectrometer. Samples
supplemented with interferents were tested by the Fungitell assay and compared
to the BG-positive sample without an interferent. To estimate minimum interfering
concentrations, interference plots for hemoglobin, bilirubin, and triglycerides
Interfering substances. Interference in the Fungitell assay due to hemolysis,bilirubin, and lipemia was assessed by supplementation of a BG-positive serumsample with each of the individual interferents (25). To prepare sufficient quantitiesof BG-positive serum samples for this study, a unit of expired fresh frozenplasma that tested negative for BG was clotted with CaCl2. Serum was collectedby centrifugation and sterilely filtered. A BG-positive serum sample control wasproduced by reconstituting lyophilized BG from Associates of Cape Cod, Inc.,with the above-processed serum to a concentration of 161 pg/ml. The BG standard(pachyman) used in this study was the same as that supplied with theFungitell kit. Bilirubin and triglycerides (Intralipid) were purchased from Sigma,St. Louis, Mo. A solution of hemoglobulin was prepared by lysis of washed redblood cells with pyrogen-free water (Associates of Cape Cod, Inc.). Stock solutionsof bilirubin, triglycerides, and hemoglobulin, prepared in pyrogen-freewater, were added individually to aliquots of the BG-positive serum preparedabove to simulate a range of bilirubin, triglyceride, and hemoglobin concentrationsof approximately 0 to 200 mg/dl, 0 to 1,000 mg/dl, and 0 to 2,500 mg/dl,respectively. Final concentrations of hemoglobin, bilirubin, and triglycerideswere determined for each aliquot. Bilirubin and triglycerides were determinedwith a Modular Analytics P instrument (Roche Diagnostics Corporation, Indianapolis,印第安纳州)使用由制造商提供的试剂。血红蛋白浓度用贝克曼库尔特杜 800 光谱仪测定了。样品辅以烟幕进行测试 Fungitell 测定和比较对 BG 阳性样品,不用组份。估计最小干扰浓度,干涉图为血红蛋白、 胆红素、 及甘油三酯
正在翻譯中..